Drug candidates in clinical trials for Alzheimer’s disease
Abstract Alzheimer’s disease (AD) is a major form of senile dementia, characterized by progressive memory and neuronal loss combined with cognitive impairment. AD is the most common neurodegenerative disease worldwide, affecting one-fifth of those aged over 85 years. Recent therapeutic approaches ha...
Main Authors: | Shih-Ya Hung, Wen-Mei Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12929-017-0355-7 |
Similar Items
-
Clinical trials of new drugs for Alzheimer disease
by: Li-Kai Huang, et al.
Published: (2020-01-01) -
Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer’s Disease, Lithium, and Autophagy
by: Odeya Damri, et al.
Published: (2021-12-01) -
The “rights” of precision drug development for Alzheimer’s disease
by: Jeffrey Cummings, et al.
Published: (2019-08-01) -
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
by: Antonio Ancidoni, et al.
Published: (2021-05-01) -
Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease
by: Leslie C. Norins
Published: (2021-03-01)